Benca, C. E. et al. 2017. Predicting Cognitive Executive Functioning with Polygenic Risk Scores for Psychiatric Disorders. Behavior Genetics 47(1), pp. 11-24. doi: 10.1007/s10519-016-9814-2
Bigdeli, T. B. et al. 2015. Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, p. No Pagination Specified.
Blokland, G. A. M. et al. 2017. Heritability of Neuropsychological Measures in Schizophrenia and Nonpsychiatric Populations: A Systematic Review and Meta-analysis. Schizophrenia Bulletin 43(4), pp. 788-800. doi: 10.1093/schbul/sbw146
Braga, R. J. et al. 2013. Anxiety comorbidity in schizophrenia. Psychiatry Research 210(1), pp. 1-7. doi: 10.1016/j.psychres.2013.07.030
Bulik-Sullivan, B. et al. 2015. An atlas of genetic correlations across human diseases and traits. Nature Genetics 47(11), pp. 1236-1241.
Byrne, E. M. et al. 2015. Seasonality shows evidence for polygenic architecture and genetic correlation with schizophrenia and bipolar disorder. Journal of Clinical Psychiatry 76(2), pp. 128-134.
Cardno, A. G. and Owen, M. J. 2014. Genetic Relationships Between Schizophrenia, Bipolar Disorder, and Schizoaffective Disorder. Schizophrenia Bulletin 40(3), pp. 504-515. doi: 10.1093/schbul/sbu016
Chatterjee, N. et al. 2016. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nature Reviews Genetics 17(7), pp. 392-406. doi: 10.1038/nrg.2016.27
Chen, S. J. et al. 2012. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. British Journal of Psychiatry 200(5), pp. 374-380. doi: 10.1192/bjp.bp.111.092098
Craddock, N. et al. 2006. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophrenia Bulletin 32(1), pp. 9-16. doi: 10.1093/schbul/sbj033
Cross-Disorder Group of the Psychiatric Genomics, C. 2013. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381(9875), pp. 1371-1379. doi: 10.1016/S0140-6736(12)62129-1
Derks, E. M. et al. 2012. Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: A polygenic risk score analysis. PLoS ONE 7 (6) (no pagination)(e37852),
Dudbridge, F. 2013. Power and Predictive Accuracy of Polygenic Risk Scores. PLoS Genetics 9(3), doi: 10.1371/journal.pgen.1003348
Eaton, W. W. et al. 2006. Association of schizophrenia and autoimmune diseases: Linkage of Danish National Registers. American Journal of Psychiatry 163(3), pp. 521-528. doi: 10.1176/appi.ajp.163.3.521
Eaton, W. W. et al. 2010. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disorders 12(6), pp. 638-646. doi: 10.1111/j.1399-5618.2010.00853.x
Euesden, J. et al. 2015. The relationship between schizophrenia and rheumatoid arthritis revisited: Genetic and epidemiological analyses. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 168(2), pp. 81-88.
Fanous, A. H. et al. 2012. Genome-wide association study of clinical dimensions of schizophrenia: Polygenic effect on disorganized symptoms. American Journal of Psychiatry 169(12), pp. 1309-1317.
Frank, J. et al. 2015. Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients. Molecular Psychiatry 20(2), pp. 150-151.
Gottesman, I. I. and Gould, T. D. 2003. The endophenotype concept in psychiatry: Etymology and strategic intentions. American Journal of Psychiatry 160(4), pp. 636-645. doi: 10.1176/appi.ajp.160.4.636
Hall, M.-H. et al. 2015. Genomewide Association Analyses of Electrophysiological Endophenotypes for Schizophrenia and Psychotic Bipolar Disorders: A Preliminary Report. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 168(3), pp. 151-161. doi: 10.1002/ajmg.b.32298
Hall, M. H. and Smoller, J. W. 2010. A New Role for Endophenotypes in the GWAS Era: Functional Characterization of Risk Variants. Harvard Review of Psychiatry 18(1), pp. 67-74. doi: 10.3109/10673220903523532
Hamshere, M. L. et al. 2011. Polygenic dissection of the bipolar phenotype. British Journal of Psychiatry 198(4), pp. 284-288. doi: 10.1192/bjp.bp.110.087866
Hamshere, M. L. et al. 2013. Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia. British Journal of Psychiatry 203(2), pp. 107-111.
Hatzimanolis, A. et al. 2015. Common genetic variation and schizophrenia polygenic risk influence neurocognitive performance in young adulthood. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 168(5), pp. 392-401.
Hettige, N. C. et al. 2016. Polygenic risk score prediction of antipsychotic dosage in schizophrenia. Schizophrenia Research 170(2-3), pp. 265-270.
Hubbard, L. et al. 2016. Evidence of Common Genetic Overlap Between Schizophrenia and Cognition. Schizophrenia Bulletin 42(3), pp. 832-842. doi: 10.1093/schbul/sbv168
Jones, A. L. et al. 2005. Immune dysregulation and self-reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis? Immunology and Cell Biology 83(1), pp. 9-17. doi: 10.1111/j.1440-1711.2005.01305.x
Jones, H. J. et al. 2016. Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population. JAMA Psychiatry 73(3), pp. 221-228.
Keshavan, M. et al. 2008. Psychopathology among offspring of parents with schizophrenia: Relationship to premorbid impairments. Schizophrenia Research 103(1-3), pp. 114-120. doi: 10.1016/j.schres.2008.03.006
Keshavan, M. S. et al. 2005. Premorbid indicators and risk for schizophrenia: A selective review and update. Schizophrenia Research 79(1), pp. 45-57. doi: 10.1016/j.schres.2005.07.004
Khandaker, G. M. et al. 2011. A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Research 132(2-3), pp. 220-227. doi: 10.1016/j.schres.2011.06.017
Laursen, T. M. et al. 2009. Bipolar Disorder, Schizoaffective Disorder, and Schizophrenia Overlap: A New Comorbidity Index. Journal of Clinical Psychiatry 70(10), pp. 1432-1438. doi: 10.4088/JCP.08m04807
Lencz, T. et al. 2014. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: A report from the Cognitive Genomics consorTium (COGENT). Molecular Psychiatry 19(2), pp. 168-174.
Liebers, D. T. et al. 2016. Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults. Schizophrenia Bulletin 42(4), pp. 984-991. doi: 10.1093/schbul/sbw001
McIntosh, A. M. et al. 2013. Polygenic risk for schizophrenia is associated with cognitive change between childhood and old age. Biological Psychiatry 73(10), pp. 938-943.
Milaneschi, Y. et al. 2016. Polygenic dissection of major depression clinical heterogeneity. Molecular Psychiatry 21(4), pp. 516-522.
Moher, D. et al. 2009. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Plos Medicine 6(7), p. 6. doi: 10.1371/journal.pmed.1000097
Mullins, N. et al. 2014. Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 165B(5), pp. 428-437.
Niemi, L. T. et al. 2003. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophrenia Research 60(2-3), pp. 239-258. doi: 10.1016/s0920-9964(02)00234-7
Nievergelt, C. M. et al. 2015. Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene. Psychoneuroendocrinology 51, pp. 459-471.
Onitsuka, T. et al. 2013. Review of neurophysiological findings in patients with schizophrenia. Psychiatry and Clinical Neurosciences 67(7), pp. 461-470. doi: 10.1111/pcn.12090